L H de Castro-Afonso1, G S Nakiri1, R S Oliveira2, M V Santos2, A C Dos Santos2, H R Machado3, D G Abud4. 1. Division of Interventional Neuroradiology, Medical School of Ribeirão Preto, University of São Paulo, Avenida Bandeirantes, 3900, Monte Alegre, Ribeirão Preto, SP, Brazil, 14048-090. 2. Division of Pediatric Neurosurgery, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. 3. Division of Diagnostic Neuroradiology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. 4. Division of Interventional Neuroradiology, Medical School of Ribeirão Preto, University of São Paulo, Avenida Bandeirantes, 3900, Monte Alegre, Ribeirão Preto, SP, Brazil, 14048-090. dgabud@fmrp.usp.br.
Abstract
INTRODUCTION: Intracranial arteriovenous malformations (AVMs) are the most frequent cause of hemorrhagic strokes in the pediatric population. The study aim was to retrospectively assess the safety and efficacy of Onyx embolization with the intention to cure AVMs in a pediatric population. METHODS: A retrospective analysis of all patients (<18 years) who underwent endovascular embolization using Onyx at our institution was conducted. The primary endpoint was the composite complete angiographic occlusion of AVM immediately after the last embolization session that had no procedure-related complication requiring emergency surgery. Secondary endpoints were angiographic occlusion rates, procedure-related complications, and clinical outcomes after treatment and at the 6-month follow-up RESULTS: Twenty-three patients (mean age, 11.7 years) underwent a total of 45 embolization sessions. The median Spetzler-Martin grade was 3 (range 1 to 4). The primary endpoint was achieved in 19 patients (82.6 %). Complete angiographic occlusion of the AVM was obtained in 21 patients (91.3 %) immediately after embolization and at the 6-month follow-up. Embolization-related complications were observed in three patients (13 %). None of the complications resulted in permanent functional disability or death. In two patients (8.7 %), the AVM could not be completely occluded by embolization alone and the patients were referred to radiosurgery and microsurgery, respectively. CONCLUSION: Onyx embolization of AVM in pediatric patients with the intention to cure resulted in high occlusion rates without increasing neurological disability or death. The development of new embolization techniques and devices seems to improve the safety of Onyx embolization.
INTRODUCTION:Intracranial arteriovenous malformations (AVMs) are the most frequent cause of hemorrhagic strokes in the pediatric population. The study aim was to retrospectively assess the safety and efficacy of Onyx embolization with the intention to cure AVMs in a pediatric population. METHODS: A retrospective analysis of all patients (<18 years) who underwent endovascular embolization using Onyx at our institution was conducted. The primary endpoint was the composite complete angiographic occlusion of AVM immediately after the last embolization session that had no procedure-related complication requiring emergency surgery. Secondary endpoints were angiographic occlusion rates, procedure-related complications, and clinical outcomes after treatment and at the 6-month follow-up RESULTS: Twenty-three patients (mean age, 11.7 years) underwent a total of 45 embolization sessions. The median Spetzler-Martin grade was 3 (range 1 to 4). The primary endpoint was achieved in 19 patients (82.6 %). Complete angiographic occlusion of the AVM was obtained in 21 patients (91.3 %) immediately after embolization and at the 6-month follow-up. Embolization-related complications were observed in three patients (13 %). None of the complications resulted in permanent functional disability or death. In two patients (8.7 %), the AVM could not be completely occluded by embolization alone and the patients were referred to radiosurgery and microsurgery, respectively. CONCLUSION: Onyx embolization of AVM in pediatric patients with the intention to cure resulted in high occlusion rates without increasing neurological disability or death. The development of new embolization techniques and devices seems to improve the safety of Onyx embolization.
Authors: Jane Skjøth-Rasmussen; Tina Obbekjær; Peter Birkeland; John Hauerberg; Marianne Juhler Journal: Childs Nerv Syst Date: 2011-12-08 Impact factor: 1.475
Authors: Rustam Al-Shahi Salman; Philip M White; Carl E Counsell; Johann du Plessis; Janneke van Beijnum; Colin B Josephson; Tim Wilkinson; Catherine J Wedderburn; Zoe Chandy; E Jerome St George; Robin J Sellar; Charles P Warlow Journal: JAMA Date: 2014 Apr 23-30 Impact factor: 56.272
Authors: Marian Gaballah; Phillip B Storm; Deborah Rabinowitz; Rebecca N Ichord; Robert W Hurst; Ganesh Krishnamurthy; Marc S Keller; Adeka McIntosh; Anne Marie Cahill Journal: J Neurosurg Pediatr Date: 2013-11-29 Impact factor: 2.375
Authors: Christian Dorfer; Thomas Czech; Gerhard Bavinzski; Klaus Kitz; Aygül Mert; Engelbert Knosp; Andreas Gruber Journal: Childs Nerv Syst Date: 2009-11-28 Impact factor: 1.475
Authors: Maryam Soltanolkotabi; Samantha E Schoeneman; Tord D Alden; Michael C Hurley; Sameer A Ansari; Arthur J DiPatri; Tadanori Tomita; Ali Shaibani Journal: J Neurosurg Pediatr Date: 2013-02-08 Impact factor: 2.375
Authors: J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz Journal: Lancet Date: 2013-11-20 Impact factor: 79.321
Authors: Travis S CreveCoeur; Afshin Salehi; Brandon A Miller; Matthew J Austin; Dewitte T Cross; Matthew D Smyth Journal: Childs Nerv Syst Date: 2018-09-10 Impact factor: 1.475